Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 75 years of age
- People who have been diagnosed with Crohn's disease for at least 3 months
- People whose Crohn's disease is considered moderate to severe, based on a standard scoring system called the CDAI (confirm with trial site)
- People who have previously been treated with a standard dose of ustekinumab and either did not respond to it from the start, responded at first but then stopped responding over time, or had to stop taking it due to side effects
Who may not be able to join:
- People who have previously been treated with a type of medication called an anti-IL-23p19 therapy, which includes a drug called guselkumab
- People who currently have an active gut infection, a bowel blockage, short bowel syndrome, a stoma, or who had an abscess in the abdomen within the past 8 weeks
- People with a history of cancer (with some exceptions for certain skin cancers), active tuberculosis, or a serious opportunistic infection
- People who are pregnant, breastfeeding, or planning to become pregnant during the time the study would be running
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 008619857407061
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients achieving clinical remission (CDAI <150 or HBI <4) at Week 52.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.